Best Recursion Pharmaceuticals Alternatives
32 alternatives in AI Healthcare
Alternatives
32
Avg Score
64/100
Top Funded
Tempus
$1.05B
Score
65
Funding
Not disclosed
Valuation
$1.79B
Alternatives & Competitors
Funding
$370M
Valuation
$957M
Country
🇺🇸 United States
Founded
2011
Funding
$1.05B
Valuation
$8.1B
Country
🇺🇸 United States
Founded
2015
Funding
$750M
Valuation
$5.83B
Country
🇫🇷 France
Founded
2016
Funding
$800M
Valuation
$5.3B
Country
🇺🇸 United States
Founded
2018
Funding
$743M
Valuation
$2.2B
Country
🇺🇸 United States
Founded
2018
Funding
$131M
Valuation
$180M
Country
🇫🇷 France
Founded
2018
Funding
$465M
Valuation
Not disclosed
Country
🇸🇬 Singapore
Founded
2015
Funding
$500M
Valuation
Not disclosed
Country
🇬🇧 United Kingdom
Founded
2012
Funding
$160M
Valuation
$270M
Country
🇮🇳 India
Founded
2016
Funding
$354M
Valuation
$1B
Country
🇫🇷 France
Founded
2016
Funding
$129M
Valuation
Not disclosed
Country
🇦🇺 Australia
Founded
2018
Funding
$180M
Valuation
Not disclosed
Country
🇨🇦 Canada
Founded
2015
Funding
$370M
Valuation
Not disclosed
Country
🇮🇱 Israel
Founded
2016
Funding
$500M
Valuation
$1.2B
Country
🇺🇸 United States
Founded
2014
Funding
$289M
Valuation
$1.2B
Country
🇺🇸 United States
Founded
2016
Funding
$241M
Valuation
Not disclosed
Country
🇺🇸 United States
Founded
2018
Funding
$120M
Valuation
Not disclosed
Country
🇺🇸 United States
Founded
2023
Funding
$264M
Valuation
Not disclosed
Country
🇮🇳 India
Founded
2013
Funding
$150M
Valuation
$829M
Country
🇰🇷 South Korea
Founded
2013
Funding
$30M
Valuation
Not disclosed
Country
🇮🇳 India
Founded
2015
Funding
$490M
Valuation
Not disclosed
Country
🇺🇸 United States
Founded
2016
Funding
$292M
Valuation
Not disclosed
Country
🇬🇧 United Kingdom
Founded
2013
Funding
$17M
Valuation
Not disclosed
Country
🇮🇳 India
Founded
2016
Funding
$20M
Valuation
Not disclosed
Country
🇮🇳 India
Founded
2015
Funding
$20M
Valuation
Not disclosed
Country
🇮🇳 India
Founded
2015
Funding
$30M
Valuation
Not disclosed
Country
🇺🇸 United States
Founded
2017
Funding
$47M
Valuation
Not disclosed
Country
🇬🇧 United Kingdom
Founded
2014
Funding
$219M
Valuation
Not disclosed
Country
🇺🇸 United States
Founded
2012
Funding
$5M
Valuation
Not disclosed
Country
🇮🇳 India
Founded
2017
Funding
$20M
Valuation
Not disclosed
Country
🇳🇱 Netherlands
Founded
2016
Funding
$66M
Valuation
Not disclosed
Country
🇬🇧 United Kingdom
Founded
2018
Funding
$3M
Valuation
Not disclosed
Country
🇳🇱 Netherlands
Founded
2017
Side-by-Side Comparison
| Metric | Recursion Pharmaceuticals | Butterfly Network | Tempus | Alan |
|---|---|---|---|---|
| Awaira Score | 65/100 | 85/100 | 84/100 | 83/100 |
| Total Funding | Not disclosed | $370M | $1.05B | $750M |
| Valuation | $1.79B | $957M | $8.1B | $5.83B |
| Founded | 2013 | 2011 | 2015 | 2016 |
| Country | United States | United States | United States | France |
| Stage | Public | Public | Public | Series D |
| Employees | 800 | 500-1000 | 2500 | 500-1000 |
Frequently Asked Questions
What are the best alternatives to Recursion Pharmaceuticals?
The strongest alternatives to Recursion Pharmaceuticals in AI Healthcare are Butterfly Network, Tempus, Alan. They're competing for similar customers and solving overlapping problems.
How does Recursion Pharmaceuticals compare to Butterfly Network?
Recursion Pharmaceuticals scores 65 on Awaira's index; Butterfly Network comes in at 85. On funding, Recursion Pharmaceuticals has raised Not disclosed versus Butterfly Network's $370M.